Concepedia

Cassandra Slader

CS

Statistics

Publications

8

Citations

1.3K

H-Index

8

Active since

2006

Affiliations

The University of Adelaide(Current)

South Australia Pathology

Novartis (Australia)

St Vincent's Hospital Melbourne

Princess Alexandra Hospital

Cassandra Slader is an author at The University of Adelaide specializing in pharmacotherapy, chronic myeloid leukemia therapy, and medicine.

Publications per year

2006–2020

8

Publications

8

Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study

David M. Ross, Susan Branford, John F. Seymour et al. · Blood · 2013 · 706 citations

, , +11

Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCR

David M. Ross, Susan Branford, John F. Seymour et al. · Leukemia · 2010 · 267 citations

, , +15

Double blind randomised controlled trial of two different breathing techniques in the management of asthma

Cassandra Slader · Thorax · 2006 · 100 citations · Full text

, , +16

Chronic phase chronic myeloid leukemia patients with low OCT-1 activity randomized to high-dose imatinib achieve better responses and have lower failure rates than those randomized to standard-dose imatinib

Deborah L. White, Jerald P. Radich, Simona Soverini et al. · Haematologica · 2011 · 63 citations · Full text

, , +10

TARGET: a survey of real‐world management of chronic myeloid leukaemia across 33 countries

Anna Turkina, Jianxiang Wang, Vikram Mathews et al. · British Journal of Haematology · 2020 · 57 citations

, , +13

1–5 of 8